QS-21 Adjuvant
Platform Technology
Information
QS-21 is one of the most studied adjuvants in human clinical history. QS-21 from another manufacturer, is now utilized in a human commercial vaccine, as part of the AS01 adjuvant system.
Desert King QS-21 is currently being evaluated in a Covid-19 vaccine candidate.
Our QS-21 vaccine adjuvant is available in both GMP and Non-GMP versions. Vials sizes are available in 5, 25 and 100 mg. We are able to supply hundreds of grams.